Meseclazone
Appearance
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H10ClNO3 |
Molar mass | 239.66 g·mol−1 |
3D model (JSmol) | |
|
Meseclazone (W-2395), also known as 2-methylseclazone, is a nonsteroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]
See also
[edit]References
[edit]- ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ^ a b c Rainsford KD (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.